...Carmen Gutierrez; Maria J. Martin; K.A. Brown A study was made of the complement activation (CA) capacity of human lymphocytes from lymphoid organs. Whereas thymocytes did not show complement membrane fluorescence (CMF) following incubation in normal homologous serum (NHS), a mean of 18 and 34...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Complement activation C3d,g Terminal complement complex Complement 2 156-164 (1985) 1605941 © 1985 S Karger AG. Basel 0253-5076 85-0023-0156$2...

... is involved when the terminal pathway of complement is activated in vivo. Quantification of TCC in plasma is an important supplement to already established methods for the evaluation of complement activation in vivo. 11 8 2017 1985 Copyright / Drug Dosage / Disclaimer Copyright: All rights...

... 1984 S. Karger AG, Basel 0253-5076/84/0012-0097S2.75/0 Quantification of Large C3 Fragments as an Index of Complement Activation in Mice I. In vitro Studies Jacqueline Lulê, Gilbert J. Fournié, Christine Bousquet, Jean-Marc Dueymes, Jacques P. Pourrat, Jean J. Conté Unité de Recherche d...

... that this method was able to detect the complement activation early, at a time when total levels of C3-reacting molecules had not yet decreased. Complement 1: 103-107 (1984) 1605971 © 1984 S. Karger AG, Basel 0253-5076/84/0012-0103S2.75/0 Quantification of Large C3 Fragments as an Index of Complement Activation...

... and orosomucoid. Median CRP concentration was 46 mg/1 in the AMI group and 2.5 in the control group. The corresponding orosomucoid concentrations were 1.6 and 1.2 g/1. There was no correlation between the concentration of CRP in peripheral blood and the degree of complement activation. Furthermore, no correlation...

...Keith Whaley Many new tests which measure complement activation are now available, although it is unclear which tests or group of tests are appropriate for monitoring complement activation in clinical samples. Carefully planned prospective studies are required to resolve this issue, and to identify...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Complement activation C3 Neoepitopes 1605820 Complement Inflamm 1989;6:205-218 © 1989 S. Karger AG, Basel 1012-8204/89...

... of human and porcine C5a, and the structural changes of C5a were suggested to occur after the removal of the carboxyl terminal arginine residue. Complement activation C5 C5a/C5a-des-Arg Neoepitopes 11 8 2017 1989 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...

.../0063-0134S2.75/0 Antigenic Changes of Complement Components: Relevance for the Analysis of Complement Activation Tom Eirik Mollnes Institute of Immunology and Rheumatology, Rikshospitalet, National Hospital, Oslo, Norway Key Words. Complement activation Antigenic changes Neoepitopes Monoclonal...

...D.I. Våge; P. Garred; T. Lea; T.E. Mollnes Eluates from one all-silicone and two different combined silicone-latex catheters and one latex and one vinyl procedure glove were mixed with normal human serum and tested in a C3 complement activation assay. Simultaneously the eluates were tested...

..., such as under in vivo conditions. Complement activation C5a neoantigen ELISA 1991 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical...

..., A.-B. Laurellh, G. Sturfeit Department of Rheumatology, University Hospital, Lund; b Department of Medical Microbiology, University of Lund, Sweden Key Words. Classical complement pathway Systemic lupus erythematosus Complement activation Cl inactivator Abstract. We studied the activation and Cl...

... in the presence of complement do not bind to autologous RBC. The same results were obtained with tetanus toxoid-anti-tetanus toxoid PIC and NIC. In order to elucidate the causes of this marked difference between the RBC-binding properties of PIC and NIC, the profile of complement activation induced by them...

...Jarmila Janatova; Alfred K. Cheung; Charles J. Parker Conventionally, complement activation by biomedical polymers has been evaluated by determining the C3a concentration in the fluid phase only. According to this criterion, biomaterials such as hemodialysis membranes made from cellulosic...